NCT06672744 is a NA clinical trial of Exercise in Superior Cluneal Nerve Entrapment, sponsored by Savaş Karpuz.

Who is sponsoring NCT06672744?

NCT06672744 is sponsored by Savaş Karpuz.

What drugs are being tested in NCT06672744?

Interventions in NCT06672744: Exercise, Myofascial release technique, Kinesiotaping.

What condition does NCT06672744 study?

NCT06672744 studies Superior Cluneal Nerve Entrapment.

Is NCT06672744 still recruiting?

NCT06672744 is currently completed. Last updated 4 November 2024.

Last reviewed 2024-11-04 · How we verify

NCT06672744

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Superior Cluneal Nerve Entrapment Syndrome, Kinesiotaping and Myofascial Release Techniques

Completed NA Last updated 4 November 2024

What this trial tests

NA trial testing Exercise in Superior Cluneal Nerve Entrapment in 75 participants. Completed in 16 August 2024.

Timeline

15 August 2022

Primary endpoint
15 August 2024

16 August 2024

Quick facts

Lead sponsor	Savaş Karpuz
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	75
Start date	15 August 2022
Primary completion	15 August 2024
Estimated completion	16 August 2024
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Exercise
Myofascial release technique
Kinesiotaping

Conditions studied

Superior Cluneal Nerve Entrapment — all drugs for Superior Cluneal Nerve Entrapment →

Sponsor

Savaş Karpuz

Who can join

18 and older, any sex, with Superior Cluneal Nerve Entrapment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Myofascial release techniques and/or kinesiotaping may be effective in the treatment of superior cluneal nerve impingement syndrome ?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

NCT06231069 — Mixed Exercise Training and Novel Multi-Nutrient Supplementation in Young Adults · NA · withdrawn
NCT07007858 — Effects of High-Velocity Passive Stretch on Spasticity, Function, and Muscle Structure in Spastic CP Children · NA · enrolling by invitation
NCT07589725 — Mulligan Mobilization in Lateral Elbow Tendinopathy · NA · not yet recruiting
NCT07524400 — Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease · NA · recruiting
NCT06627569 — Exercise Effects on the Neurobiology Underlying Stress-related Eating Behaviors in Veterans · NA · not yet recruiting

Other Savaş Karpuz trials

Trials by the same sponsor.

NCT07010172 — Fibromyalgia, Cognitive Rehabilitation Software · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06672744 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Savaş Karpuz
Last refreshed: 4 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06672744.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing